InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Yazji Salim, Directeur Médical. Officer active across 1 companies, notably Oncternal Therapeutics, Inc.. In total, 4 disclosures have been recorded. Total volume traded: €30k. The latest transaction was filed on 27 January 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations4 total
€15,03110,000 shares@ €1.5031100.0% of flow
Common Stock
SEC:0001209191-22-005557·
Ideal exit: 24 Oct 2022 (T+270)
€15,03110,000 shares@ €1.503150.0% of flow
Common Stock
SEC:0001209191-22-005557:0·
Ideal exit: 24 Oct 2022 (T+270)
057,137 shares0
Common Stock
SEC:0001209191-22-001975·
057,137 shares0
Common Stock
SEC:0001209191-22-001975:0·
4 of 4 declarations
About Yazji Salim
Salim Yazji is the Chief Medical Officer at Oncternal Therapeutics, Inc. He oversees the company's medical initiatives, including product development and clinical trials. His medical expertise is crucial for the strategic direction of research and development programs.
